NTLA vs CRSP
NTLA and CRSP side by side — valuation & fundamentals (public data).
Key statistics
| Metric | NTLAINTELLIA THERAPEUTICS, INC. | CRSPCRISPR THERAPEUTICS AG |
|---|---|---|
| Market cap | $1.49B | $4.63B |
| P/S | 22.1x | 1317.7x |
| Revenue growth (YoY) | 16.9% | -90.6% |
| Earnings growth (YoY) | 20.5% | -58.8% |
| EBIT margin | -651.7% | -18933.6% |
| ROE | -66.5% | -32.1% |
| ROIC | — | -33.6% |
| 1y total return | -8.2% | -14.7% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: NTLA vs CRSP
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)